Humatica advises Intermediate Capital Group (ICG) on their investment in Lucid Group

ndetails

Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Intermediate Capital Group (ICG) on its investment in Lucid Group.

Founded in 2007, Lucid Group is a strategic healthcare communications company committed to advancing patient health outcomes through healthcare communications that improve the way patients and diseases are managed, and medicines are used. Lucid Group’s pioneering approaches have received industry-wide recognition and have consistently led to above industry growth.

With offices in the UK, US and Asia, Lucid now employs around 250 people. Lucid works in partnership with the world’s leading pharmaceutical and biotech organisations and has played a pivotal role in providing healthcare communication solutions for many of the industry’s innovative blockbuster assets.

Humatica was engaged by ICG to provide Organisational Due Diligence advice for this transaction.

Patrick Mina, Managing Partner UK of Humatica, commented:

“We were delighted to support ICG with pre-deal stage Organisational Due Diligence on Lucid where we helped to identify areas of focus for the value creation plan. We are proud to have assisted ICG on this transaction and look forward to supporting their growth plans in the future.”

Peter Kirtley, ICG’s Managing Director, added:

“ICG is a leading global alternative asset manager, with a long and successful track record of providing capital to support founder-led growing businesses like Lucid Group. We have admired Lucid Group and its reputation within the industry for many years. Through our partnership, together, we can leverage Lucid’s ambition and our sector expertise to build a truly global healthcare communications organisation.”

The Humatica team was led by Patrick Mina, Managing Partner UK and Head of the London office, supported by Humatica Directors Valentina Pozzobon and Andreas Knobloch.

To download the news release in PDF format, click here.

Related News

Humatica recognized for Best Organizational Due Diligence Solution 2024
20 Feb, 2024 By Humatica

Humatica recognized for Best Organizational Due Diligence Solution 2024

Humatica was recognized for having the Best Organizational Due Diligence Solution by Private Equity Wire in their 2024 European Awards. The award was based on…

Read more arrowicon
Humatica recognized as Best Specialist Private Equity Consulting Firm 2023
23 Nov, 2023 By Humatica

Humatica recognized as Best Specialist Private Equity Consulting Firm 2023

Wealth & Finance International Magazine has announced the winners of this year’s Management Consulting Awards. For the second year running, the Management Consulting Awards looks…

Read more arrowicon
Humatica advises Freshstream on its investment in Project Better Energy
09 Nov, 2023 By Humatica

Humatica advises Freshstream on its investment in Project Better Energy

Humatica advises Freshstream on their investment on Project Better Energy, one of the leading players in the domestic renewable energy sector in the UK  Humatica, the…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.